ShareValue scores for 300267.SHE: Valuation 53, Quality 30, Growth 31, Health 52.

300267.SHE
SZSE

Hunan Er Kang Pharmaceutical

CN¥3.24(+3.85%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 16%
Valuation
53
Fair Value
Price vs Value
Quality
30
Weak
Business Strength
Growth
31
Weak
Revenue & Earnings
Health
52
Moderate
Financial Stability
Momentum
28
Bearish
Price Trend

Company Details

About

Hunan Er-Kang Pharmaceutical Co., Ltd engages in the research and development, production, and sale of pharmaceutical excipients, APIs and finished drugs in China and internationally. The company offers various APIs, such as glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, dihydroxypropyl theophylline, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. It also provides finished drugs, including sulbenicillin sodium for injection and compound liquorice tablets. In addition, the company offers conventional pharmaceutical excipients, such as pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprising of hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate products. Hunan Er-Kang Pharmaceutical Co., Ltd was founded in 2003 and is based in Changsha, China. Address: Liuyang Economic Development Zone, Changsha, China, 410331

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026